Menu
MorphoSys US

Investor & Media information

You are here

  1. Home
  2. Media and investors
  3. Investor & Media information

MorphoSys is strictly committed to the principle of fair disclosure. One of the most important foundations of our corporate communication is to inform all stakeholders simultaneously and comprehensively about the situation of the Company. We pay great attention to transparent and timely communication.

Corporate media releases

Date
Title

2020

  1. 13/10/2020
    Ad hoc: MorphoSys AG Launches an Offering of approx. EUR 325 Million Convertible Bonds
  2. 30/09/2020
    MorphoSys Announces Departure of Jens Holstein, CFO, by Year End 2020
  3. 17/09/2020
    MorphoSys and Incyte to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas
  4. 17/09/2020
    MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer
  5. 18/08/2020
    National Comprehensive Cancer Network(R) Adds Monjuvi(R) (tafasitamab-cxix) to its Clinical Practice Guidelines in Oncology for B-cell Lymphomas
  6. 05/08/2020
    MorphoSys Reports Second Quarter and First Half 2020 Results
  7. 01/08/2020
    FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
  8. 01/08/2020
    MorphoSys AG: Ad hoc: FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
  9. 30/07/2020
    Invitation to MorphoSys' Second Quarter and First Half 2020 Results Conference Call on August 6, 2020
  10. 14/07/2020
    MorphoSys' Licensee Janssen Announces Approval of Tremfya (Guselkumab) by U.S. FDA for Treatment of Adults with Active Psoriatic Arthritis

Pages

Order form for publications and reports

Ad-hoc releases

Sorry, but there are no ad-hoc releases available for the selected year.

Pages

Conferences

Tuesday, June 8, 2021
Fireside Chat: Goldman Sachs 42nd Annual Global Healthcare Conference

Dr. Jean-Paul Kress (CEO) presents the Company at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021, at 3:00 PM EDT / 8:00 PM BST.

Go to Fireside Chat...

Archive

Date
Title
MP3

2021

  1. 06/08/2021

    Fireside Chat: Goldman Sachs 42nd Annual Global Healthcare Conference

  2. 06/02/2021

    Conference Call

  3. 05/25/2021

    Webcast: UBS Global Healthcare Conference

  4. 05/06/2021

    Conference Call and Webcast: First Quarter Results 2021

  5. 03/16/2021

    Conference Call and Webcast: Year End 2020

  6. 02/26/2021

    Webcast: 10th Annual SVB Leerink Global Healthcare Conference

  7. 02/11/2021

    Guggenheim Healthcare Talks, 2021 Oncology Day

  8. 01/13/2021

    Webcast: 39th Annual J.P. Morgan Healthcare Conference

2020

  1. 12/16/2020

    Webcast: JMP Securities Hematology Summit

  2. 11/17/2020

    Stifel 2020 Virtual HC Conference

  3. 11/12/2020

    Conference Call and Webcast: Q3/9M 2020 Financial Results

  4. 09/29/2020

    Conference Call and Webcast: MorphoSys & Incyte Tafasitamab Expert Event

  5. 08/06/2020

    Conference Call and Webcast: Q2/H1 2020 Financial Results

  6. 08/03/2020

    Joint MorphoSys and Incyte Conference Call

  7. 06/18/2020

    Webcast: JMP Securities Hematology and Oncology Forum

Pages

Company Update

Date
Venue
Download

2020

  1. 01/13/2021
    Company Update

Pictures

Technology

Ylanthia

Ylanthia technology

Slonomics

Slonomics technology

HuCAL

HuCAL antibody library

HuCAL

Scientist working with the HuCAL library

Lab shots

Antibody purification

Scientist in protein chemistry lab

Daily work

MorphoSys scientist working in laboratory

Scientist with petri dishes

MorphoSys scientist handling petri dishes

Cell culture experiment

MorphoSys scientist in cell culture lab

Miscellaneous

MorphoSys Building Planegg

View of the Building of MorphoSys in Planegg/Munich, Germany

MorphoSys Building Planegg

Entrance of the Building of MorphoSys in Planegg/Munich, Germany

MorphoSys Logo
MorphoSys Footage Video

Copyright notice: The photos provided for download on this website can be used free of charge in the context of editorial reporting with the indication of the photo credit "©MorphoSys AG".

 

You are leaving morphosys.com and will be transferred to the MorphoSys US website which is intended for US residents.

Do you wish to proceed?

Yes No

You are leaving morphosys.com and will be transferred to the MorphoSys US website which is intended for US residents.

Do you wish to proceed?

Yes No

You are leaving morphosys.com and will be transferred to the Monjuvi(®) US website which is intended for US residents.

Do you wish to proceed?

Yes No